Halter F, Huber R, Häcki W H, Varga L, Bachmann C
Eur J Clin Invest. 1982 Jun;12(3):209-17. doi: 10.1111/j.1365-2362.1982.tb00995.x.
In order to estimate their in-vivo reactivity two antacids of equal theoretical neutralizing capacity (approximately 3.9 mol/l at pH 3.5) but of different chemical composition were employed as intragastric titrant (pH 3.5) following a liquid protein meal (oxo) in two groups of five volunteers each. The two antacids chosen (alucol and Camalox) contain different amounts of aluminium hydroxide, magnesium hydroxide and Camalox in addition contains calcium carbonate. The intragastric consumption of these two antacids was much higher than their respective theoretically available neutralizing capacity (Alucol 3.9 times, Camalox 2.4 times). In-vitro studies demonstrated that interaction with oxo reduced the neutralizing capacity of the two antacids at pH 3.5 from 3.9 mol/l to 1.7 mol/l (Alucol) and 2.5 mol/l (Camalox). This potency loss was related to the aluminium hydroxide content of the two antacids. This study indicates that the neutralizing capacity of antacids is not predictable from their reactivity in aqueous solution and is markedly reduced by protein-containing foods.
为了评估两种理论中和能力相同(在pH 3.5时约为3.9摩尔/升)但化学成分不同的抗酸剂的体内反应性,在两组每组五名志愿者摄入液体蛋白质餐(oxo)后,将它们用作胃内滴定剂(pH 3.5)。所选用的两种抗酸剂(alucol和卡马罗克斯)含有不同量的氢氧化铝、氢氧化镁,并且卡马罗克斯还含有碳酸钙。这两种抗酸剂的胃内消耗量远高于它们各自理论上可利用的中和能力(alucol为3.9倍,卡马罗克斯为2.4倍)。体外研究表明,与oxo相互作用会使这两种抗酸剂在pH 3.5时的中和能力从3.9摩尔/升降至1.7摩尔/升(alucol)和2.5摩尔/升(卡马罗克斯)。这种效力损失与这两种抗酸剂的氢氧化铝含量有关。这项研究表明,抗酸剂的中和能力无法根据其在水溶液中的反应性来预测,并且会因含蛋白质的食物而显著降低。